PhaseBio Pharmaceuticals, Inc. Common Stock

PHAS

Market cap $3.5M

Delisted

PHAS was delisted on the 2nd of November, 2022.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	HI 26 Harbour Investments Madison, Wisconsin	$2K	–	–	–
27	27 Osaic Holdings Scottsdale, Arizona	$1K	–	–	–
28	TWC 28 TD Waterhouse Canada Toronto, Ontario, Canada	$211	–	–	–
29	29 BNP Paribas Financial Markets Paris, France	$14	–	–	–
30	CA 30 CHI Advisors New York	–	-$450K	-750,000	Closed
31	NLG 31 New Legacy Group New York	–	-$144K	-240,575	Closed
32	32 Marshall Wace London, United Kingdom	–	-$73K	-123,039	Closed
33	33 Citadel Advisors Miami, Florida	–	-$65K	-107,953	Closed
34	34 Prudential Financial Newark, New Jersey	–	-$26K	-44,100	Closed
35	VF 35 Virtu Financial New York	–	-$19K	-31,852	Closed
36	36 Millennium Management New York	–	-$8K	-13,501	Closed
37	TSS 37 Two Sigma Securities New York	–	-$8K	-12,845	Closed
38	38 Two Sigma Advisers New York	–	-$8K	-12,700	Closed
39	39 UBS Group Zurich, Switzerland	–	-$6K	-9,830	Closed
40	40 Citigroup New York	–	-$6.02K	-5,900	-98%
41	41 Toronto Dominion Bank Toronto, Ontario, Ontario, Canada	–	-$3K	-4,670	Closed
42	42 Wells Fargo San Francisco, California	–	+$14	+14	+0.8%
43	43 Royal Bank of Canada Toronto, Ontario, Canada	–	+$189	+185	+9%
44	44 Simplex Trading Chicago, Illinois	–	+$3.38K	+3,317	New